# Gala FIH Feasibility Study for the Treatment of Chronic Bronchitis

> **NCT03107494** · NA · COMPLETED · sponsor: **Gala Therapeutics, Inc.** · enrollment: 18 (actual)

## Conditions studied

- Chronic Bronchitis

## Interventions

- **DEVICE:** Gala Airway Treatment System

## Key facts

- **NCT ID:** NCT03107494
- **Lead sponsor:** Gala Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-20
- **Primary completion:** 2019-02-28
- **Final completion:** 2019-11-30
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2020-09-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03107494

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03107494, "Gala FIH Feasibility Study for the Treatment of Chronic Bronchitis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03107494. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*